DPEP3 (US10189910B2 Biosimilar) Recombinant Monoclonal Antibody

This recombinant monoclonal antibody is developed as a research-grade biosimilar to the reference antibody described in patent US10189910B2, specifically targeting DPEP3 (Dipeptidase 3). DPEP3 is a membrane-bound metallopeptidase that catalyzes the hydrolysis of dipeptides and plays a role in cellular metabolism and peptide processing. This enzyme belongs to the dipeptidase family and is expressed in various tissues, where it participates in the final steps of protein degradation and amino acid recycling. DPEP3 has been implicated in metabolic processes and may have relevance in studies of cellular homeostasis and nutrient sensing pathways.

The reference antibody outlined in US10189910B2 provides a well-characterized framework for investigating DPEP3 expression and function in biological systems. This biosimilar antibody serves as a valuable research tool for scientists studying dipeptidase biology, metabolic regulation, and related cellular mechanisms. It enables researchers to explore DPEP3's role in various physiological and pathological contexts, supporting investigations into enzyme function and potential disease associations.